Boeck S - Search Results

1

Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.

Kruger S, Schirle K, Haas M, Crispin A, Schirra J, Mayerle J, D'Haese JG, Kunz WG, Ricke J, Ormanns S, Kirchner T, Kobold S, Ilmer M, Gebauer L, Westphalen CB, von Bergwelt-Baildon M, Werner J, Heinemann V, Boeck S. Kruger S, et al. Among authors: boeck s. J Cancer Res Clin Oncol. 2020 Feb;146(2):391-399. doi: 10.1007/s00432-019-03061-4. Epub 2019 Oct 23. J Cancer Res Clin Oncol. 2020. PMID: 31642961

2

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.

Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Boeck S, et al. Oncology. 2006;70(4):255-64. doi: 10.1159/000094888. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899980 Free article. Review.

3

RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.

Fahrig R, Quietzsch D, Heinrich JC, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Hänel M. Fahrig R, et al. Among authors: boeck s. Anticancer Drugs. 2006 Oct;17(9):1045-56. doi: 10.1097/01.cad.0000231472.92406.d2. Anticancer Drugs. 2006. PMID: 17001178

4

Importance of performance status for treatment outcome in advanced pancreatic cancer.

Boeck S, Hinke A, Wilkowski R, Heinemann V. Boeck S, et al. World J Gastroenterol. 2007 Jan 14;13(2):224-7. doi: 10.3748/wjg.v13.i2.224. World J Gastroenterol. 2007. PMID: 17226900 Free PMC article. Review.

5

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.

Boeck S, Weigang-Köhler K, Fuchs M, Kettner E, Quietzsch D, Trojan J, Stötzer O, Zeuzem S, Lordick F, Köhne CH, Kröning H, Steinmetz T, Depenbrock H, Heinemann V. Boeck S, et al. Ann Oncol. 2007 Apr;18(4):745-51. doi: 10.1093/annonc/mdl463. Epub 2007 Jan 17. Ann Oncol. 2007. PMID: 17229775 Free article. Clinical Trial.

6

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?

Boeck S, Schulz C, Stieber P, Holdenrieder S, Weckbach S, Heinemann V. Boeck S, et al. Onkologie. 2007 Feb;30(1-2):39-42. doi: 10.1159/000097764. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264524 Free article.

7

[Molecular-based treatment concepts in advanced pancreatic cancer].

Boeck S, Moosmann N, Stemmler HJ, Heinemann V. Boeck S, et al. Dtsch Med Wochenschr. 2007 Apr 13;132(15):818-22. doi: 10.1055/s-2007-973627. Dtsch Med Wochenschr. 2007. PMID: 17427093 Review. German. No abstract available.

8

[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].

Moosmann N, Boeck S, Heinemann V. Moosmann N, et al. Among authors: boeck s. Med Klin (Munich). 2007 Jul 15;102(7):551-62; quiz 563-4. doi: 10.1007/s00063-007-1069-5. Med Klin (Munich). 2007. PMID: 17634873 German. No abstract available.

9

Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer.

Boeck S, Hausmann A, Reibke R, Schulz C, Heinemann V. Boeck S, et al. Anticancer Drugs. 2007 Oct;18(9):1109-11. doi: 10.1097/CAD.0b013e3281ceabec. Anticancer Drugs. 2007. PMID: 17704662

10

Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

Boeck S, Wollenberg A, Heinemann V. Boeck S, et al. Ann Oncol. 2007 Sep;18(9):1582-3. doi: 10.1093/annonc/mdm420. Ann Oncol. 2007. PMID: 17761714 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters